Skip to Main content Skip to Navigation
Journal articles

Clinical Pharmacokinetics of Daptomycin

Abstract : Due to the low level of resistance observed with daptomycin, this antibiotic has an important place in the treatment of severe Gram-positive infections. It is the first-in-class of the group of calcium-dependent, membrane-binding lipopeptides, and is a cyclic peptide constituted of 13 amino acids and an n-decanoyl fatty acid chain. The antibacterial action of daptomycin requires its complexation with calcium. Daptomycin is not absorbed from the gastrointestinal tract and needs to be administered parenterally. The distribution of daptomycin is limited (volume of distribution of 0.1 L/kg in healthy volunteers) due to its negative charge at physiological pH and its high binding to plasma proteins (about 90%). Its elimination is mainly renal, with about 50% of the dose excreted unchanged in the urine, justifying dosage adjustment for patients with renal insufficiency. The pharmacokinetics of daptomycin are altered under certain pathophysiological conditions, resulting in high interindividual variability. As a result, therapeutic drug monitoring of daptomycin may be of interest for certain patients, such as intensive care unit patients, patients with renal or hepatic insufficiency, dialysis patients, obese patients, or children. A target for the ratio of the area under the curve to the minimum inhibitory concentration > 666 is usually recommended for clinical efficacy, whereas in order to limit the risk of undesirable muscular effects the residual concentration should not exceed 24.3 mg/L.
Document type :
Journal articles
Complete list of metadata
Contributor : Alexia Chauzy Connect in order to contact the contributor
Submitted on : Wednesday, December 16, 2020 - 9:40:04 AM
Last modification on : Wednesday, April 13, 2022 - 1:28:02 PM
Long-term archiving on: : Wednesday, March 17, 2021 - 6:30:04 PM


Files produced by the author(s)




Nicolas Gregoire, Alexia Chauzy, Julien Buyck, Blandine Rammaert, William Couet, et al.. Clinical Pharmacokinetics of Daptomycin. Clinical Pharmacokinetics, Springer Verlag, 2020, ⟨10.1007/s40262-020-00968-x⟩. ⟨hal-03071620⟩



Record views


Files downloads